Westlake, Texas, USA – May 21, 2026
Virbac, a global leader in animal health and veterinary care, announced that its C.E.T. AQUADENT® FR3SH® Dental Solution has officially earned the prestigious Veterinary Oral Health Council (VOHC®) Seal of Acceptance for helping control both plaque and tartar in dogs. The recognition further strengthens Virbac’s position in the rapidly growing pet oral healthcare market and reinforces the reputation of the C.E.T.® product line as one of the most trusted veterinarian-recommended dental brands worldwide.
The latest VOHC acceptance also highlights increasing awareness among veterinarians and pet owners regarding the importance of preventive oral healthcare for companion animals. Dental disease remains one of the most common health conditions affecting dogs and cats globally, creating rising demand for scientifically validated at-home dental care solutions. Virbac’s newest milestone reflects the broader trend toward preventive veterinary medicine and daily wellness-focused pet care products.
VOHC Recognition Strengthens Virbac’s Dental Care Leadership
The Veterinary Oral Health Council is widely regarded as one of the most respected independent authorities evaluating animal oral healthcare products. Overseen by the American Veterinary Dental College, the organization reviews scientific evidence to determine whether products effectively reduce plaque and tartar accumulation in animals. Products receiving the VOHC Seal of Acceptance are considered to meet rigorous efficacy standards recognized across the veterinary industry.
According to Virbac, the newly approved C.E.T. AQUADENT® FR3SH® Dental Solution is specifically designed to help maintain fresh breath and support healthy gums in both dogs and cats. The product uses the company’s proprietary FR3SH® Technology, a blend of natural active ingredients including erythritol, inulin, and pomegranate extract, which help reduce plaque formation during routine daily use.
Advertisement
The solution is administered simply by adding it to a pet’s water bowl, making it easier for pet owners to incorporate dental care into everyday routines without requiring brushing or more complex oral hygiene procedures. Veterinary experts note that convenient at-home solutions may significantly improve compliance among pet owners and contribute to better long-term oral health outcomes in companion animals.
Virbac executives described the latest VOHC recognition as a reflection of the company’s continued investment in science-driven veterinary innovation. Company leadership emphasized that every VOHC Seal reinforces veterinarian confidence in recommending C.E.T.® products as evidence-based oral care solutions supported by clinical validation and measurable results.
Pet Dental Health Gains Attention Worldwide
Veterinary dental health has become an increasingly important focus within companion animal medicine as studies continue to show links between poor oral health and broader systemic health complications. Untreated plaque and tartar buildup can contribute to gum disease, tooth loss, chronic pain, bacterial infections, and reduced quality of life in pets. In severe cases, oral bacteria may also affect organs such as the heart, liver, and kidneys.
Industry analysts report that pet owners are becoming more proactive about preventive healthcare, particularly as companion animals are increasingly viewed as family members. This shift is driving rapid growth in the global pet wellness and veterinary oral care markets, including products such as dental chews, water additives, oral rinses, and specialized veterinary diets.
Virbac’s latest recognition arrives at a time when veterinary professionals are encouraging earlier intervention and routine dental maintenance to reduce the long-term health burden associated with periodontal disease. Daily plaque control remains one of the most effective strategies for preserving oral health and minimizing costly veterinary dental procedures later in life.
Veterinary Innovation Expands Preventive Animal Healthcare
Virbac continues to expand its portfolio of veterinary products and services across more than 100 countries worldwide. The company develops preventive and therapeutic healthcare solutions for over 50 animal species, covering diagnostics, vaccines, pharmaceuticals, dermatology, nutrition, and oral health.
Analysts believe the VOHC recognition may further strengthen Virbac’s competitive position within the companion animal healthcare market, especially as consumer demand for veterinarian-endorsed preventive wellness products continues to rise globally. The company’s emphasis on science-backed innovation aligns with broader trends in veterinary medicine focused on preventive care, quality of life, and long-term health management for pets.
The approval of C.E.T. AQUADENT® FR3SH® also demonstrates how veterinary healthcare companies are increasingly investing in products that combine convenience, efficacy, and scientific validation to meet evolving consumer expectations in modern pet care.
Source: Virbac press release
